BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23161504)

  • 1. Meta-analysing randomised controlled trials with omega-3 fatty acids in cardiovascular disease.
    von Schacky C
    Evid Based Med; 2013 Aug; 18(4):e33. PubMed ID: 23161504
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary cardiovascular prevention: omega-3 fatty acids ineffective.
    Prescrire Int; 2013 Sep; 22(141):218. PubMed ID: 24171221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acids and secondary prevention of cardiovascular disease-is it just a fish tale?: comment on “Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease”.
    Hu FB; Manson JE
    Arch Intern Med; 2012 May; 172(9):694-6. PubMed ID: 22493410
    [No Abstract]   [Full Text] [Related]  

  • 4. The big ones that got away: omega-3 meta-analysis flawed by excluding the biggest fish oil trials.
    DiNicolantonio JJ; O'Keefe JH; Lavie CJ
    Arch Intern Med; 2012 Oct; 172(18):1427; author reply 1427-8. PubMed ID: 23045179
    [No Abstract]   [Full Text] [Related]  

  • 5. Omega-3 Fatty Acids and Cardiovascular Disease Prevention.
    Tomdio A; Ritchie M; Miller AC
    Am Fam Physician; 2019 Aug; 100(4):209-210. PubMed ID: 31414778
    [No Abstract]   [Full Text] [Related]  

  • 6. Omega-3 Fatty Acids and Primary and Secondary Prevention of Cardiovascular Disease.
    Cao Y; Lu L; Liang J; Liu M; Li X; Sun R; Zheng Y; Zhang P
    Cell Biochem Biophys; 2015 May; 72(1):77-81. PubMed ID: 25427890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reply to the editor.
    Costanzo S; Di Castelnuovo A; Iacoviello L
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):992-3. PubMed ID: 24041166
    [No Abstract]   [Full Text] [Related]  

  • 8. Omega-3 polyunsaturated fatty acids: is their future VITALized or REDUCEd?
    Gajos G
    Cardiovasc Res; 2019 May; 115(6):e58-e60. PubMed ID: 31077585
    [No Abstract]   [Full Text] [Related]  

  • 9. Supplementation of n-3 polyunsaturated fatty acids to prevent postoperative atrial fibrillation in patients subjected to heart surgery.
    Messori A; Fadda V; Maratea D
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):991-2. PubMed ID: 24041165
    [No Abstract]   [Full Text] [Related]  

  • 10. Omega-3 fatty acids and cardiovascular risk.
    Kruse LG; Ogletree RL
    J Miss State Med Assoc; 2013 Jun; 54(6):156-7. PubMed ID: 23991511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ω-3 fatty acid supplements for secondary prevention of cardiovascular disease: from "no proof of effectiveness" to "proof of no effectiveness".
    Messori A; Fadda V; Maratea D; Trippoli S
    JAMA Intern Med; 2013 Aug; 173(15):1466-8. PubMed ID: 23779264
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of omega-fatty acids in cardiovascular prevention].
    Rumboldt Z
    Lijec Vjesn; 2009; 131(3-4):103-4. PubMed ID: 19514259
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of cardiovascular diseases with omega-3-fatty acids and vitamins?].
    Musch A
    Med Monatsschr Pharm; 2006 Mar; 29(3):109. PubMed ID: 16550885
    [No Abstract]   [Full Text] [Related]  

  • 14. Rebuttal to Aung et al, "Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals".
    von Schacky C
    Altern Ther Health Med; 2018 Mar; 24(2):8-9. PubMed ID: 29859508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 polyunsaturated fatty acid in primary and secondary cardiovascular disease prevention.
    Chalupka S
    AAOHN J; 2009 Nov; 57(11):480. PubMed ID: 19968213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of omega-3 polyunsaturated fatty acids in cardiovascular health.
    Barrett SJ
    Altern Ther Health Med; 2013; 19 Suppl 1():26-30. PubMed ID: 23981464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 for patients with cardiovascular disease.
    Turgeon R; Janke F; Kolber MR
    Can Fam Physician; 2012 Nov; 58(11):1225. PubMed ID: 23152459
    [No Abstract]   [Full Text] [Related]  

  • 18. Omega-3 fatty acids: recommendations for therapeutics and prevention.
    Hutchins H; Vega CP
    MedGenMed; 2005 Oct; 7(4):18. PubMed ID: 16614640
    [No Abstract]   [Full Text] [Related]  

  • 19. Omega-3 Fatty Acid Supplements and Risk of CHD.
    Rosenberg K
    Am J Nurs; 2018 May; 118(5):69. PubMed ID: 29698285
    [No Abstract]   [Full Text] [Related]  

  • 20. Omega-3 fatty acid supplementation and cardiovascular disease events.
    Galli C; Brenna JT
    JAMA; 2013 Jan; 309(1):28-9. PubMed ID: 23280211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.